Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly …
Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Day One Biopharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
Day One Biopharmaceuticals, Inc. has no acquisition track records yet.